Concert Pharmaceuticals to Present at Upcoming Investor Conferences
August 29 2018 - 7:00AM
Business Wire
Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced
that it will present a corporate overview at the following upcoming
investor conferences:
- The Wells Fargo Securities 2018
Healthcare Conference on September 5, 2018 at 10:15 a.m. ET in
Boston;
- The H.C. Wainwright 20th Annual Global
Investment Conference on September 6, 2018 at 10:00 a.m. ET in New
York;
- The Janney Montgomery Scott Healthcare
Conference 2018 on September 17, 2018 at 9:05 a.m. ET in New York;
and
- The 2018 Cantor Global Healthcare
Conference on October 3, 2018 at 10:20 a.m. ET in New York.
A live webcast of these presentations may be accessed in the
Investors section of the Company’s website at
www.concertpharma.com. Please log on to the Concert website
approximately 15 minutes prior to the scheduled webcast to ensure
adequate time for any software downloads that may be required. A
replay of the investor conference webcasts will be available on
Concert’s website for two weeks following each presentation.
About ConcertConcert Pharmaceuticals is a clinical stage
biopharmaceutical company focused on applying its DCE Platform®
(deuterated chemical entity platform) to create novel medicines
designed to treat serious diseases and address unmet patient needs.
The Company’s approach starts with previously studied compounds,
including approved drugs, in which deuterium substitution has the
potential to enhance clinical safety, tolerability or efficacy.
Concert has a broad pipeline of innovative medicines
targeting autoimmune and inflammatory diseases and central nervous
systems (CNS) disorders. For more information please visit
www.concertpharma.com or follow us on Twitter at @ConcertPharma or
on LinkedIn.
Concert Pharmaceuticals Inc., the CoNCERT
Pharmaceuticals Inc. logo and DCE Platform are registered
trademarks of Concert Pharmaceuticals, Inc.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20180829005047/en/
Concert Pharmaceuticals, Inc.Justine Koenigsberg,
781-674-5284ir@concertpharma.com
Concert Pharmaceuticals (NASDAQ:CNCE)
Historical Stock Chart
From Mar 2024 to Apr 2024
Concert Pharmaceuticals (NASDAQ:CNCE)
Historical Stock Chart
From Apr 2023 to Apr 2024